Skip Navigation


Brain Advance Access originally published online on March 23, 2005
Brain 2005 128(6):1247-1258; doi:10.1093/brain/awh488
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
128/6/1247    most recent
awh488v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (41)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Williams, D. R.
Right arrow Articles by Lees, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Williams, D. R.
Right arrow Articles by Lees, A. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author (2005). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please e-mail: journals.permissions@oupjournals.org

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

David R. Williams1,2, Rohan de Silva2,3, Dominic C. Paviour1,4, Alan Pittman2, Hilary C. Watt3,5, Linda Kilford1,4, Janice L. Holton1,2,3, Tamas Revesz1,3 and Andrew J. Lees1,2,4

1 The Queen Square Brain Bank for Neurological Disorders, 2 Reta Lila Weston Institute for Neurological Studies and 3 Institute of Neurology, University College London, 4 Sara Koe PSP Research Centre and 5 Medical Statistics Unit, London School of Hygiene and Tropical Medicine, London, UK

Correspondence to: Professor Andrew J. Lees, Reta Lila Weston Institute for Neurological Studies, 46 Cleveland St, London W1T 4JF, UK E-mail: alees{at}ion.ucl.ac.uk

The clinical diagnosis of progressive supranuclear palsy (PSP) relies on the identification of characteristic signs and symptoms. A proportion of pathologically diagnosed cases do not develop these classic features, prove difficult to diagnose during life and are considered as atypical PSP. The aim of this study was to examine the apparent clinical dichotomy between typical and atypical PSP, and to compare the biochemical and genetic characteristics of these groups. In 103 consecutive cases of pathologically confirmed PSP, we have identified two clinical phenotypes by factor analysis which we have named Richardson's syndrome (RS) and PSP-parkinsonism (PSP-P). Cases of RS syndrome made up 54% of all cases, and were characterized by the early onset of postural instability and falls, supranuclear vertical gaze palsy and cognitive dysfunction. A second group of 33 (32%) were characterized by asymmetric onset, tremor, a moderate initial therapeutic response to levodopa and were frequently confused with Parkinson's disease (PSP-P). Fourteen cases (14%) could not be separated according to these criteria. In RS, two-thirds of cases were men, whereas the sex distribution in PSP-P was even. Disease duration in RS was significantly shorter (5.9 versus 9.1 years, P < 0.001) and age at death earlier (72.1 versus 75.5 years, P = 0.01) than in PSP-P. The isoform composition of insoluble tangle-tau isolated from the basal pons also differed significantly. In RS, the mean four-repeat:three-repeat tau ratio was 2.84 and in PSP-P it was 1.63 (P < 0.003). The effect of the H1,H1 PSP susceptibility genotype appeared stronger in RS than in PSP-P (odds ratio 13.2 versus 4.5). The difference in genotype frequencies between the clinical subgroups was not significant. There were no differences in apolipoprotein E genotypes. The classic clinical description of PSP, which includes supranuclear gaze palsy, early falls and dementia, does not adequately describe one-third of cases in this series of pathologically confirmed cases. We propose that PSP-P represents a second discrete clinical phenotype that needs to be clinically distinguished from classical PSP (RS). The different tau isoform deposition in the basal pons suggests that this may ultimately prove to be a discrete nosological entity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BrainHome page
S. S. O'Sullivan, L. A. Massey, D. R. Williams, L. Silveira-Moriyama, P. A. Kempster, J. L. Holton, T. Revesz, and A. J. Lees
Clinical outcomes of progressive supranuclear palsy and multiple system atrophy
Brain, May 1, 2008; 131(5): 1362 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. R. Williams, A. J. Lees, J. R. Wherrett, and J. C. Steele
J. Clifford Richardson and 50 years of progressive supranuclear palsy
Neurology, February 12, 2008; 70(7): 566 - 573.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
Z. Ahmed, K. A. Josephs, J. Gonzalez, A. DelleDonne, and D. W. Dickson
Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy
Brain, February 1, 2008; 131(2): 460 - 472.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
A. Quattrone, G. Nicoletti, D. Messina, F. Fera, F. Condino, P. Pugliese, P. Lanza, P. Barone, L. Morgante, M. Zappia, et al.
MR Imaging Index for Differentiation of Progressive Supranuclear Palsy from Parkinson Disease and the Parkinson Variant of Multiple System Atrophy
Radiology, December 1, 2007; 246(1): 214 - 221.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. D. Kaat, A.J.W. Boon, W. Kamphorst, R. Ravid, H. J. Duivenvoorden, and J. C. van Swieten
Frontal presentation in progressive supranuclear palsy
Neurology, August 21, 2007; 69(8): 723 - 729.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. R. Williams, J. L. Holton, C. Strand, A. Pittman, R. de Silva, A. J. Lees, and T. Revesz
Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome
Brain, June 1, 2007; 130(6): 1566 - 1576.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
L. I. Golbe and P. A. Ohman-Strickland
A clinical rating scale for progressive supranuclear palsy
Brain, June 1, 2007; 130(6): 1552 - 1565.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
A. Lannuzel, G. U. Hoglinger, S. Verhaeghe, L. Gire, S. Belson, M. Escobar-Khondiker, P. Poullain, W. H. Oertel, E. C. Hirsch, B. Dubois, et al.
Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Brain, March 1, 2007; 130(3): 816 - 827.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
A. Schrag, C. Selai, N. Quinn, A. Lees, I. Litvan, A. Lang, Y. Poon, J. Bower, D. Burn, and J. Hobart
Measuring quality of life in PSP: The PSP-QoL.
Neurology, July 11, 2006; 67(1): 39 - 44.
[Abstract] [Full Text] [PDF]

Home page
 PNHome page
K. S M Taylor and C. Counsell
Is it Parkinson's disease, and if not, what is it?
Practical Neurology, June 1, 2006; 6(3): 154 - 165.
[Full Text] [PDF]

Home page
 BrainHome page
K. A. Josephs, J. R. Duffy, E. A. Strand, J. L. Whitwell, K. F. Layton, J. E. Parisi, M. F. Hauser, R. J. Witte, B. F. Boeve, D. S. Knopman, et al.
Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech
Brain, June 1, 2006; 129(6): 1385 - 1398.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
D R Williams, H C Watt, and A J Lees
Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study
J. Neurol. Neurosurg. Psychiatry, April 1, 2006; 77(4): 468 - 473.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. C. Paviour, S. L. Price, M. Jahanshahi, A. J. Lees, and N. C. Fox
Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy
Brain, April 1, 2006; 129(4): 1040 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
S. A. Factor, D. S. Higgins, and J. Qian
Primary progressive freezing gait: A syndrome with many causes
Neurology, February 14, 2006; 66(3): 411 - 414.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.